Hypothyroidism
📧 Sign up to get email alerts when something new happens for Hypothyroidism.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-10-31FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for levothyroxine sodium from Accord Healthcare Inc. under an ANDA.
-
FDA approval · 2022-09-16FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Accord Healthcare Inc.)
The FDA approved a supplemental application for Accord Healthcare's levothyroxine sodium, a generic thyroid hormone replacement product.
-
FDA label_change · 2022-08-30FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Synthroid (levothyroxine sodium) submitted by AbbVie, resulting in changes to the product la…
-
CLINICAL_TRIALS withdrawal · 2022-07-13Clinical Trial Update: Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery [Phase 2, Phase 3]
Clinical trial for levothyroxine in subclinical hypothyroidism after head and neck surgery was withdrawn.
-
FDA approval · 2022-06-22FDA Approved: TIROSINT — Supplemental Application (IBSA Pharma Inc.)
The FDA approved a supplemental application for TIROSINT (levothyroxine sodium) filed by IBSA Pharma Inc., typically resulting in labeling u…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-05-10FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva’s generic levothyroxine sodium product under an Original Application (ANDA 207588).
-
FDA approval · 2022-04-29FDA Approved: ERMEZA — Original Application (Viatris Specialty LLC)
ERMEZA has been approved by the FDA through an original NDA for levothyroxine sodium, a thyroid hormone replacement used to treat hypothyroi…
-
FDA approval · 2022-04-27FDA Approved: EUTHYROX — Supplemental Application (Provell Pharmaceuticals, LLC)
The FDA approved a supplemental application for EUTHYROX (levothyroxine sodium) from Provell Pharmaceuticals, LLC, updating an existing NDA …
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Pediatric Risk of Hypothyroidism With Iodinated Contrast Media [Phase 4]
Phase 4 clinical trial update on pediatric risk of hypothyroidism with iodinated contrast media; study withdrawn.
-
FDA label_change · 2022-04-14FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Alvogen, Inc.)
FDA approved a supplemental application for Levothyroxine Sodium submitted by Alvogen, Inc., resulting in updated labeling for the product.
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors [Phase 4]
Phase 4 trial update on levothyroxine sodium in thyroidectomized patients taking proton pump inhibitors; results posted.
-
CLINICAL_TRIALS research · 2022-02-18Clinical Trial Update: Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients. [Phase 4]
A Phase 4 trial exploring how a Type 2 Deiodinase gene polymorphism affects treatment of hypothyroidism in thyroid cancer patients post-thyr…
-
CLINICAL_TRIALS withdrawal · 2021-09-22Clinical Trial Update: Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding [Phase 4]
Phase 4 trial investigating changes in levothyroxine dosage for hypothyroidism patients started on enteral feeding was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Hypothyroidism Treated With Calcitonin [Phase 4]
Phase 4 clinical trial evaluating calcitonin for hypothyroidism has completed with posted results.
-
FDA approval · 2021-05-17FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a Levothyroxine Sodium original application product from Hikma Pharmaceuticals USA Inc. as a thyroid hormone replacement therap…
-
FDA approval · 2021-05-17FDA Approved: LIOTHYRONINE SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for liothyronine sodium from Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Identification of Non-responders to Levothyroxine Therapy [Phase 2]
Phase 2 trial update investigating identification of non-responders to levothyroxine therapy in hypothyroidism, with biomarker focus.
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: A Comparative Study of New Formulation and Approved Formulation for Levothyroxine in Healthy Volunteers [Phase 1]
Phase 1 trial comparing a new formulation of levothyroxine with the approved formulation in healthy volunteers has completed with results po…
-
FDA approval · 2021-01-22FDA Approved: LIOTHYRONINE SODIUM — Original Application (Zydus Lifesciences Limited)
FDA approved a generic liothyronine sodium product from Zydus Lifesciences Limited under an Original Application (ANDA). It is used for the …
-
FDA approval · 2020-11-30FDA Approved: THYQUIDITY — Original Application (Oliva Therapeutics, LLC)
FDA approved THYQUIDITY (levothyroxine sodium) from Oliva Therapeutics, LLC via an Original New Drug Application.
-
FDA approval · 2020-11-05FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Levothyroxine Sodium from Mylan Pharmaceuticals under an ANDA, authorizing the change descri…
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism [Phase 4]
Phase 4 trial update on growth hormone and GnRH agonist in adolescents with acquired hypothyroidism; study terminated with results posted.
-
FDA approval · 2020-10-19FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Accord Healthcare Inc.)
FDA approved an original application for Levothyroxine Sodium from Accord Healthcare Inc. as a generic thyroid hormone replacement product.
-
FDA label_change · 2020-07-15FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Synthroid (levothyroxine sodium) by AbbVie, resulting in a labeling change. The action updates t…
-
CLINICAL_TRIALS research · 2020-04-13Clinical Trial Update: Bone Structure and Strength Evaluated by Extreme-CT Scan Before and After Treatment of Hyper- and Hypothyroidism
A completed clinical trial evaluating bone structure and strength using extreme-CT scans before and after treatment for hyperthyroidism and …